Illumina Ventures is a genomics and precision health venture firm that invests in early-stage companies. It leverages its strategic relationship with Illumina and offers capital, sequencing, mentorship, and lab capabilities to build market-leading companies in life sciences tools, diagnostics, therapeutics, digital health, and sustainability.
Recent Transactions involving Illumina Ventures
Deal | Target | Platform | Buyer | Industry |
---|---|---|---|---|
Genome Medical Announces Acquisition of GeneMatters and Closing of $60 Million Series C Financing |
GeneMatters |
Genome Medical |
Casdin CapitalGVIllumina VenturesLRVHealthEcho Health VenturesRevelation PartnersHealthInvest Equity PartnersAvestria VenturesFlywheel VenturesDreamers FundBlue Ivy VenturesAmgen VenturesCanaan PartnersKaiser Permanente VenturesPerceptive Advisors |
Medical Practices |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →